. Archives of Disease in Childhood, 45, 763. Hydroxyproline excretion and height velocity in adolescent boys. The height velocity of 122 boys of 11 to 17 years is compared with their urinary total hydroxyproline excretion and a close relation is shown. The importance of this is discussed in relation to undersized children and to those with scoliosis in whom rapid growth is often associated with increasing curvature of the spine. Poor correlation was found between urinary total hydroxyproline excretion and height, weight, body surface area, and creatinine excretion.
The growth of children may be studied by height and weight measurements or by radiographic studies of bone. Though both are useful neither avoids the difficulty that normal variations may be wide, particularly during the adolescent growth 'spurt'.
Measurements of height and weight are easy to make and are of interest for immediate assessment. Reference to centile charts, such as those of Tanner, Whitehouse, and Takaishi (1966) will enable a child to be compared with others of the same age. It is future growth, however, not present height, which is often the physician's main concern. Will the now undersized child grow more rapidly later on? Predictions of adult height may be made from present height for children from 3 years of age until puberty (Tanner, 1962) . At adolescence an assessment of the degree of skeletal maturity present may be made from a radiograph of the wrist. This is an additional help. If tables such as those by Bayley and Pinneau (1952) are used, relating the Greulich and Pyle (1959) (Ziff et al., 1956; Dull, Causing, and Henneman, 1962; Kivirikko and Laitinen, 1965) .
Received 5 May 1970. Younoszai (1967) showed that in infants between 3 and 17 weeks of age there is a direct relation between daily hydroxyproline excretion and the rate of linear growth. Prockop and Kivirikko (1967) showed that the excretion was greater in normal children than in adults. Anderson, Bannister, and Tomlinson (1965) suggested that the highest excretion levels were found in 6 to 10-year-old girls and 11 to 15-year-old boys and that children generally excrete more hydroxyproline than adults. Jones et al. (1964) suggested that peak excretion levels are found in children of 14 and 15 years, and that there is good correlation between hydroxyproline excretion and growth. In our study of normal children we have examined the relation of total hydroxyproline excretion to height, weight, body surface area, and creatinine excretion. We have found poor correlation in all cases (Table I ) but have been impressed by the apparent similarity between the rise and fall of the mean total hydroxyproline excretion and the growth velocity of children of similar age (Tanner, 1962) . We now present further evidence that this relationship is very close.
Method
In October 1967 the urinary total hydroxyproline excretion in 24 hours was estimated for a group of boarding-school boys aged 11 to 18 years at the Royal Hospital School, Ipswich, while on a collagen-free diet (Zorab, 1969) . Two years later we returned to this school and studied the height record of 207 boys whose termly measurements had been recorded during the two years before and after the urinary estimation, by the same school staff. We drew the growth curve for each Zorab, Clark, Harrison, and Seel (Fig. 1) . The PHV was taken as occurring at the end of the year of maximum growth.
We also analysed the mean annual height increment for five groups of 11 to 15-year-old boys, each group having an increased level of hydroxyproline excretion. These levels were then related to growth performance during one year before and two years after the urinary estimation (Fig. 2) . Results
It will be seen that the curves of mean height velocity and total hydroxyproline excretion are very similar (Fig. 1) . Those with the lowest total hydroxyproline excretion are found either two years before or after the peak of their height velocity. 
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Those with the highest levels are found within a few months of their peak velocity. Details are given in Table II . 
